Open AccessLizinopril in the Treatment of Arterial Hypertension
Author(s) -
В. И. Подзолков,
A. I. Tarsimanova
Publication year - 2017
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2017.9.10031
Subject(s) - lisinopril , medicine , selection (genetic algorithm) , angiotensin converting enzyme , cardiology , pharmacology , blood pressure , computer science , artificial intelligence
Despite availability of a wide selection of antihypertensive drugs, only a small portion of patients with arterial hypertension are treated effectively. Angiotensin converting enzyme inhibitors (ACEI) are considered drugs of first choice for starting therapy of uncomplicated arterial hypertension. Among large number of representatives of this class lisinopril deserves special attention as one of best known and well-studied ACEIs. Wide spectrum of activity and proven organoprotective qualities of lisinopril allow to use it a variety of situations.